HIGHLIGHTS
- who: Ruijun Pan from the obtained after all patients provided with written informed consentsTissue microarrays of primary CRC tissues were purchased from Wuhan Google Biotechnology Co [, ]. Ltd. Our study procedures were approved by the Ethics Committee of the Ruijin Hospital Shanghai Jiao Tong University School of Medicine (No.SHDC CR3034). have published the Article: SFMBT1 facilitates colon cancer cell metastasis and drug resistance combined with HMG20A, in the Journal: (JOURNAL) of 30/04/2022
- what: The authors investigate the interactions between SFMBT1 and HMG20A and Official journal of CDDpress 2 the impact of 5-FU . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.